cdmo.directory
← Compare landing

Carbogen Amcis vs WuXi XDC

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryCarbogen AmcisWuXi XDC
SummaryFull-service CDMO offering integrated drug substance and sterile drug product development and manufacturing from early phase through commercialization, with specialized capabilities in API synthesis, process development, analytical services, and stability testing across multiple scales.WuXi XDC is a leading CRDMO offering integrated discovery, development, and cGMP manufacturing services for antibody drug conjugates (ADCs) and bioconjugates, with proximately located facilities that reduce development timelines and costs.
Services
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Flow Chemistry & Continuous Manufacturing
  • Solid-State Chemistry & Polymorph Screening
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • ADC Payload & Linker Synthesis
  • Bioconjugation Services
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Lyophilization (Freeze Drying)
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • ADC Payload & Linker Synthesis
  • Bioconjugation Services
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Lyophilization (Freeze Drying)
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
Modalities
  • Small Molecule
  • Antibody-Drug Conjugate (ADC)
  • Biologics (Monoclonal Antibodies)
  • Antibody-Drug Conjugate (ADC)
Development capabilities
  • Analytical method development
  • Formulation development
  • ICH stability testing
  • Solid-state characterization
  • Analytical method development
  • Formulation development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Lyophilized Vials
  • Max chemical: Commercial (>100 kg / tonne)
  • HPAPI
  • Flow Chemistry
  • Hydrogenation
  • Cryogenic (−80 °C)
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Lyophilized Vials
  • Expression: Mammalian
Locations
  • Bubendorf (Headquarters), Bubendorf, Basel-Landschaft, Switzerland
  • Aarau, Aarau, Aargau, Switzerland
  • Neuland, Hunzenschwil, Aargau, Switzerland
  • Vionnaz, Vionnaz, Valais, Switzerland
  • France, France, France
  • United Kingdom, United Kingdom, United Kingdom
  • Netherlands, Netherlands, Netherlands
  • China, China, China
  • Headquarters, Bubendorf, Basel-Landschaft, Switzerland
  • Switzerland, Switzerland, Switzerland
  • UK, UK, United Kingdom
  • France, France, France
  • Netherlands, Netherlands, Netherlands
  • Shanghai, Shanghai, Shanghai, China
  • Headquarters, China
  • Singapore Site, Singapore, Singapore
Certifications
  • NMPA · Identifier: GMP
  • NMPA · Identifier: GMP Compliance
  • NMPA · Identifier: GMP compliant
  • NMPA · Identifier: GMP Compliance (Shanghai site, unannounced inspection, no observations)
  • CIA · Identifier: Chemical Industries Association Recognition
Data not yet provided.

Find similar companies

Carbogen Amcis alternatives · WuXi XDC alternatives

Markdown mirror: /compare/carbogen-amcis/wuxi-xdc.md